Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| MAX | Nonko Eugene | Director | 20.07.2026 | Verkauf | 13,87 | 4.952 | 68.685 | Form 4 |
| MARA | Nowaid Zabi | General Counsel | 20.07.2026 | Verkauf | 12,00 | 8.376 | 100.512 | Form 4 |
| MDGL | Sibold William John | President and CEO | 20.07.2026 | Verkauf | 555,05 | 280 | 155.414 | Form 4 |
| MDGL | Sibold William John | President and CEO | 20.07.2026 | Verkauf | 550,72 | 1 | 551 | Form 4 |
| MDGL | Sibold William John | President and CEO | 20.07.2026 | Verkauf | 550,01 | 153 | 84.152 | Form 4 |
| MDGL | Sibold William John | President and CEO | 20.07.2026 | Verkauf | 548,87 | 47 | 25.797 | Form 4 |
| MDGL | Sibold William John | President and CEO | 20.07.2026 | Verkauf | 547,70 | 680 | 372.435 | Form 4 |
| MDGL | Sibold William John | President and CEO | 20.07.2026 | Verkauf | 547,08 | 269 | 147.164 | Form 4 |
| MDGL | Sibold William John | President and CEO | 20.07.2026 | Verkauf | 545,71 | 275 | 150.070 | Form 4 |
| MDGL | Sibold William John | President and CEO | 20.07.2026 | Verkauf | 544,71 | 545 | 296.869 | Form 4 |
| MDGL | Sibold William John | President and CEO | 20.07.2026 | Verkauf | 543,79 | 110 | 59.817 | Form 4 |
| MDGL | Sibold William John | President and CEO | 20.07.2026 | Verkauf | 542,75 | 140 | 75.984 | Form 4 |
| MLYS | Rodman David Malcom | Chief Medical Officer | 17.07.2026 | Verkauf | 26,53 | 416 | 11.036 | Form 4 |
| MLYS | Rodman David Malcom | Chief Medical Officer | 17.07.2026 | Optionsausübung | 15,44 | 416 | 6.423 | Form 4 |
| MPLT | Kreitzer Anatol | Chief Discovery Officer | 17.07.2026 | Verkauf | 38,39 | 200 | 7.678 | Form 4 |
| MPLT | Kreitzer Anatol | Chief Discovery Officer | 17.07.2026 | Verkauf | 37,70 | 14.140 | 533.078 | Form 4 |
| MPLT | Kreitzer Anatol | Chief Discovery Officer | 17.07.2026 | Verkauf | 37,05 | 2.833 | 104.963 | Form 4 |
| MPLT | Gillis Jonathan | CAO and Interim CFO | 17.07.2026 | Verkauf | 38,17 | 900 | 34.353 | Form 4 |
| MPLT | Gillis Jonathan | CAO and Interim CFO | 17.07.2026 | Verkauf | 37,61 | 16.969 | 638.204 | Form 4 |
| MPLT | Gillis Jonathan | CAO and Interim CFO | 17.07.2026 | Verkauf | 36,51 | 600 | 21.906 | Form 4 |
| MARA | Thiel Frederick G | Chief Executive Officer | 17.07.2026 | Verkauf | 10,90 | 27.505 | 299.805 | Form 4 |
| MARA | Khan Salman Hassan | Chief Financial Officer | 17.07.2026 | Verkauf | 10,90 | 16.000 | 174.400 | Form 4 |
| MDGL | Sibold William John | President and CEO | 17.07.2026 | Optionsausübung | — | 50.000 | — | Form 4 |
| MAX | Yi Steven | See Remarks | 17.07.2026 | Verkauf | 14,20 | 12.333 | 175.095 | Form 4 |
| MAX | Yeh Kuanling Amy | Chief Technology Officer | 17.07.2026 | Verkauf | 13,95 | 3.000 | 41.850 | Form 4 |
| MPLT | Foff Erin Pennock | Chief Medical Officer | 17.07.2026 | Verkauf | 37,90 | 3.656 | 138.562 | Form 4 |
| MPLT | Hanson Kristopher | General Counsel | 17.07.2026 | Verkauf | 37,90 | 1.130 | 42.827 | Form 4 |
| MPLT | Lillie James Woodruff | Chief Scientific Officer | 17.07.2026 | Verkauf | 37,90 | 2.077 | 78.718 | Form 4 |
| MPLT | Kroeger Christopher A. | Chief Executive Officer | 17.07.2026 | Verkauf | 37,90 | 16.779 | 635.924 | Form 4 |
| MS | Pizzi Michael A. | Head Technology & Operations | 17.07.2026 | Verkauf | 216,88 | 7.101 | 1.540.065 | Form 4 |
| MS | Pizzi Michael A. | Head Technology & Operations | 17.07.2026 | Verkauf | 215,00 | 17.064 | 3.668.760 | Form 4 |
| MNKD | Thomson David | EVP Genl Counsel & Secretary | 17.07.2026 | Verkauf | 4,05 | 24.109 | 97.641 | Form 4 |
| MNKD | Binder Steven B. | Director | 17.07.2026 | Verkauf | 4,06 | 52.485 | 213.089 | Form 4 |
| MYPS | Zanella Steven J | Director | 16.07.2026 | Zuteilung | — | 120.000 | — | Form 4 |
| MYPS | Horowitz Hyman Joseph | Director | 16.07.2026 | Zuteilung | — | 120.000 | — | Form 4 |
| MYPS | Krikorian Jason | Director | 16.07.2026 | Zuteilung | — | 120.000 | — | Form 4 |
| MYPS | Mencher Judy K | Director | 16.07.2026 | Zuteilung | — | 120.000 | — | Form 4 |
| MPLT | Kreitzer Anatol | Chief Discovery Officer | 16.07.2026 | Verkauf | 37,44 | 1.592 | 59.604 | Form 4 |
| MPLT | Kreitzer Anatol | Chief Discovery Officer | 16.07.2026 | Verkauf | 36,66 | 7.464 | 273.630 | Form 4 |
| MPLT | Gillis Jonathan | CAO and Interim CFO | 16.07.2026 | Verkauf | 37,44 | 1.476 | 55.261 | Form 4 |
| MPLT | Gillis Jonathan | CAO and Interim CFO | 16.07.2026 | Verkauf | 36,66 | 6.979 | 255.850 | Form 4 |
| MRCY | Nearhos Barry R | Director | 16.07.2026 | Zuteilung | — | 170 | — | Form 4 |
| MAX | Yi Steven | See Remarks | 16.07.2026 | Verkauf | 14,39 | 82.457 | 1.186.564 | Form 4 |
| MAX | Yeh Kuanling Amy | Chief Technology Officer | 16.07.2026 | Verkauf | 14,51 | 10.000 | 145.080 | Form 4 |
| MPLT | Foff Erin Pennock | Chief Medical Officer | 16.07.2026 | Verkauf | 37,96 | 19 | 721 | Form 4 |
| MPLT | Foff Erin Pennock | Chief Medical Officer | 16.07.2026 | Verkauf | 37,26 | 5.865 | 218.530 | Form 4 |
| MPLT | Foff Erin Pennock | Chief Medical Officer | 16.07.2026 | Verkauf | 36,46 | 9.163 | 334.083 | Form 4 |
| MPLT | Hanson Kristopher | General Counsel | 16.07.2026 | Verkauf | 37,96 | 11 | 418 | Form 4 |
| MPLT | Hanson Kristopher | General Counsel | 16.07.2026 | Verkauf | 37,26 | 3.331 | 124.113 | Form 4 |
| MPLT | Hanson Kristopher | General Counsel | 16.07.2026 | Verkauf | 36,45 | 4.776 | 174.085 | Form 4 |
| MPLT | Lillie James Woodruff | Chief Scientific Officer | 16.07.2026 | Verkauf | 37,96 | 12 | 456 | Form 4 |
| MPLT | Lillie James Woodruff | Chief Scientific Officer | 16.07.2026 | Verkauf | 37,26 | 3.526 | 131.379 | Form 4 |
| MPLT | Lillie James Woodruff | Chief Scientific Officer | 16.07.2026 | Verkauf | 36,45 | 5.009 | 182.578 | Form 4 |
| MPLT | Kroeger Christopher A. | Chief Executive Officer | 16.07.2026 | Verkauf | 37,96 | 92 | 3.492 | Form 4 |
| MPLT | Kroeger Christopher A. | Chief Executive Officer | 16.07.2026 | Verkauf | 37,26 | 28.091 | 1.046.671 | Form 4 |
| MPLT | Kroeger Christopher A. | Chief Executive Officer | 16.07.2026 | Verkauf | 36,46 | 40.899 | 1.491.178 | Form 4 |
| MS | Yeshaya Sharon | Chief Financial Officer | 16.07.2026 | Verkauf | 222,51 | 9.172 | 2.040.862 | Form 4 |
| MS | Yeshaya Sharon | Chief Financial Officer | 16.07.2026 | Verkauf | 222,51 | 6.382 | 1.420.059 | Form 4 |
| MDB | Merriman Dwight A | Director | 16.07.2026 | Verkauf | 333,42 | 2.774 | 924.907 | Form 4 |
| MDB | Merriman Dwight A | Director | 16.07.2026 | Verkauf | 329,54 | 80 | 26.363 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).